pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption

Journal of Virology

Volumn 82, Issue 9, 2008, Pages 4511-4520

  Seifried, L A ^a   Talluri, S ^a   Cecchini, M ^a   Julian, L M ^a   Mymryk, J S ^a   Dick, F A ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Cancer Research Labs   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

E1A PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ADENOVIRUS; ARTICLE; BINDING SITE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; VIRUS INFECTION; VIRUS RESISTANCE;

ADENOVIRIDAE; ADENOVIRUS E1A PROTEINS; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; MICE; MULTIPROTEIN COMPLEXES; RETINOBLASTOMA PROTEIN;

ADENOVIRIDAE;

EID: 42449085368     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02713-07     Document Type: Article

References (50)

1. Awakumov, N., A. E. Kajon, R. C. Hoeben, and J. S. Mymryk. 2004. Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses. Virology 329:477-492.
2. Bagchi, S., P. Raychaudhuri, and J. E. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659-669.
3. Berk, A. J. 2005. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 24:7673-7685.
4. Berton, T. R., D. L. Mitchell, R. Guo, and D. G. Johnson. 2005. Regulation of epidermal apoptosis and DNA repair by E2F1 in response to ultraviolet B radiation. Oncogene 24:2449-2460.
5. Binne, U. K., M. K. Classon, F. A. Dick, W. Wei, M. Rape, W. G. Kaelin, Jr., A. M. Naar, and N. J. Dyson. 2007. Retinoblastoma protein and anaphase-promoting complex physically interact and functionally cooperate during cell-cycle exit. Nat. Cell Biol. 9:225-232.
6. Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and T. Kouzarides. 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597-601.
7. Chau, B. N., C. W. Pan, and J. Y. Wang. 2006. Separation of anti-proliferation and anti-apoptotic functions of retinoblastoma protein through targeted mutations of its A/B domain. PLoS ONE 1:e82.
8. Chellappan, S., S. Hiebert, M. Mudryj, J. Horowitz, and J. Nevins. 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053-1061.
9. Chellappan, S., K. B. Kraus, B. Kroger, K. Munger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and the human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
10. Dick, F. A., and N. Dyson. 2003. pRB contains an E2F1 specific binding domain that allows E2F1 induced apoptosis to be regulated separately from other E2F activities. Mol. Cell 12:639-649.
11. Dick, F. A., and N. Dyson. 2002. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins. J. Virol. 76:6224-6234.
12. Dick, F. A., E. Sailhamer, and N. J. Dyson. 2000. Mutagenesis of the pRB pocket domain reveals that cell cycle arrest functions are separable from binding to viral oncoproteins. Mol. Cell. Biol. 20:3715-3727.
13. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245-2262.
14. Dyson, N., P. Guida, C. McCall, and E. Harlow. 1992. Adenovirus E1A makes two distinct contacts with the retinoblastoma protein. J. Virol. 66:4606-4611.
15. Faha, B. F., E. Harlow, and E. M. Lees. 1993. The adenovirus E1A-associated kinase consists of cyclin E/p33cdk2 and cyclin A/p33cdk2. J. Virol. 67:2456-2465.
16. Fattaey, A. R., E. Harlow, and K. Helin. 1993. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes. Mol. Cell. Biol. 13:7267-7277.
17. Field, S. J., F.-Y. Tsai, F. Kuo, A. M. Zubiaga, W. G. Kaelin, Jr., D. M. Livingston, S. H. Orkin, and M. E. Greenberg. 1996. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85:549-561.
18. Figge, J., T. Webster, T. F. Smith, and E. Paucha. 1988. Prediction of similar transforming regions in simian virus 40 large T, adenovirus E1A, and myc oncoproteins. J. Virol. 62:1814-1818.
19. Flinterman, M. B., J. S. Mymryk, P. Klanrit, A. F. Yousef, S. W. Lowe, C. Caldas, J. Gaken, F. Farzaneh, and M. Tavassoli. 2007. p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing. Oncogene 26:6863-6874.
20. Hurford, R., D. Cobrinik, M-H. Lee, and N. Dyson. 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447-1463.
21. Isaac, C. E., S. M. Francis, A. L. Martens, L. M. Julian, L. A. Seifried, N. Erdmann, U. K. Binne, L. Harrington, P. Sicinski, N. J. Dyson, and F. A. Dick. 2006. The retinoblastoma protein regulates pericentric heterochromatin. Mol. Cell. Biol. 26:3659-3671.
22. Ji, P., H. Jiang, K. Rekhtman, J. Bloom, M. Ichetovkin, M. Pagano, and L. Zhu. 2004. An Rb-Skp2-p27 pathway mediates acute cell cycle inhibition by Rb and is retained in a partial-penetrance Rb mutant. Mol. Cell 16:47-58.
23. Johnson, D. G., and J. Degregori. 2006. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr. Mol. Med. 6:731-738.
24. Julian, L. M., O. Palander, L. A. Seifried, J. E. G. Foster, and F. A. Dick. 24 September 2007, posting date. Characterization of an E2F1-specific binding domain in pRB and its implications for apoptotic regulation. Oncogene. doi:10.1038/sj.onc.1210803.
25. Kaczmarek, L., B. Ferguson, M. Rosenberg, and R. Baserga. 1986. Induction of cellular DNA synthesis by purified adenovirus E1A proteins. Virology 152:1-10.
26. Kovesdi, I., R. Reichel, and J. R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45:219-228.
27. Lai, A., J. M. Lee, W. M. Yang, J. A. DeCaprio, W. G. J. Kaelin, E. Seto, and P. E. Branton. 1999. RBP1 recruits both histone deacetylase-dependent and -independent repression activities to retinoblastoma family proteins. Mol. Cell. Biol. 19:6632-6641.
28. Lin, W. C., F. T. Lin, and J. R. Nevins. 2001. Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation. Genes Dev. 15:1833-1844.
29. Liu, X., and R. Marmorstein. 2007. Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation or a tumor suppressor. Genes Dev. 21:2711-2716.
30. Luo, R. X., A. A. Postigo, and D. C. Dean. 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463-473.
31. Magnaghi, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. Le Villain, F. Troalen, D. Trouche, and A. Harel-Bellan. 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601-604.
32. Mal, A., A. Piotrkowski, and M. L. Harter. 1996. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes. J. Virol. 70:2911-2921.
33. Mymryk, J. S., K. Shire, and S. T. Bayley. 1994. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block. Oncogene 9:1187-1193.
34. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
35. Nevins, J. R. 1982. Induction of the synthesis of a 70,000 dalton mammalian heat shock protein by the adenovirus E1A gene product. Cell 29:913-919.
36. Nielsen, S. J., R. Schneider, U. M. Bauer, A. J. Bannister, A. Morrison, D. O'Carroll, R. Firestein, M. Geary, T. Jenuwein, R. E. Herrera, and T. Kouzarides. 2001. Rb targets histone H3 methylation and HP1 to promoters. Nature 412:561-565.
37. Pediconi, N., A. Ianari, A. Costanzo, L. Belloni, R. Gallo, L. Cimino, A. Porcellini, A. Screpanti, I. Screpanti, C. Balsano, E. Alesse, A. Gulino, and M. Levrero. 2003. Differential regulation of E2F1 apoptotic target genes in response to DNA damage. Nat. Cell Biol. 5:552-558.
38. Phelps, W. C., C. L. Yee, K. Munger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
39. Raychaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Kraus, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein that are required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200-1211.
40. 2/M checkpoints. Genes Dev. 16:245-256.
41. Rubin, S. M., A. L. Gall, N. Zheng, and N. P. Pavletich. 2005. Structure of the Rb C-terminal domain bound to E2F1-DP1: a mechanism for phosphorylation-induced E2F release. Cell 123:1093-1106.
42. Samuelson, A. V., and S. W. Lowe. 1997. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. Proc. Natl. Acad. Sci. USA 94:12094-12099.
43. Stabel, S., P. Argos, and K. Philipson. 1985. The release of growth arrest by microinjection of adenovirus E1A DNA. EMBO J. 4:2329-2336.
44. Stevens, C., L. Smith, and N. B. La Thangue. 2003. Chk2 activates E2F-1 in response to DNA damage. Nat. Cell Biol. 5:401-409.
45. Tremblay, M. L., C. J. McGlade, G. E. Gerber, and P. E. Branton. 1988. Identification of the phosphorylation sites in early region 1A proteins of adenovirus type 5 by amino acid sequencing of peptide fragments. J. Biol. Chem. 263:6375-6383.
46. Trimarchi, J. M., and J. A. Lees. 2002. Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3:11-20.
47. Wells, J., K. Boyd, C. Fry, S. Hartley, and P. Farnham. 2000. Target gene specificity of E2F and pocket protein family members in living cells. Mol. Cell. Biol. 20:5797-5807.
48. White, E., D. Spector, and W. Welch. 1988. Differential distribution of the adenovirus E1A proteins and colocalization of E1A with the 70-kilodalton cellular heat shock protein in infected cells. J. Virol. 62:4153-4166.
49. Wikonkal, N. M., E. Remenyik, D. Knezevic, W. Zhang, M. Liu, H. Zhao, T. R. Berton, D. G. Johnson, and D. E. Brash. 2003. Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice. Nat. Cell Biol. 5:655-660.
50. Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and N. Dyson. 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537-548.